|Bid||174.67 x 300|
|Ask||174.73 x 100|
|Day's Range||172.10 - 175.45|
|52 Week Range||133.64 - 184.21|
|PE Ratio (TTM)||16.57|
|Dividend & Yield||4.60 (2.77%)|
|1y Target Est||N/A|
Health care stocks got a lift Thursday after Senate Republicans rolled out their proposed bill to repeal Obamacare.
Nasdaq 100 futures edged higher Thursday morning as Oracle surged on strong earnings. On Wednesday, Celgene broke out as biotechs and business software increasingly lead the market rally.
Given the company’s industry leading position, solid fundamentals and attractive stock valuation, we view it as a preferable alternative to traditional competitors in its industry.